Health Trials

About this trial

The study will be conducted in 2 overlapping phases. In Phase 1, there will be a 3-arm randomized controlled trial of Remote Simultaneous Medical Interpreting/RSMI (Arm 1), versus Remote Consecutive Medical Interpreting/RCMI (Arm 2) and versus Remote Consecutive Video Medical Interpreting/RCVI (Arm 3) in breast cancer outpatient clinical encounters with Spanish- and Mandarin-speaking patients with Limited English Proficiency/LEP (Stages II and III disease) and English- speaking providers (who do not speak Spanish/Mandarin). In Phase 2, there will be a sequential mixed-methods explanatory, multi-stakeholder process evaluation to gather implementation potential data.

Eligibility criteria

Qualifiers

Age >=18 years (per EMR)

Preferred language for healthcare is Spanish or Mandarin (per self-report)

Limited English Proficient; cannot speak English "very well" (per self-report)

Diagnosis of breast cancer or gastrointestinal (per EMR)

Disqualifiers

Has significant psychiatric disturbance (i.e., acute psychiatric symptoms) sufficient to preclude completion of the assessments, interviews, or informed consent (per EMR, patient's care team, or study team)

Presence of cognitive impairment disorder (i.e., delirium or dementia) sufficient to preclude meaningful informed consent and/or data collection (per EMR, patients, care team, or study team)

None

None

Trial design

Treatments tested in this trial

  • Remote Simultaneous Medical Interpreting/RSMI
  • Remote Consecutive Medical Interpreting/RCMI
  • Remote Consecutive Video Medical Interpreting/RCVI

Treatment groups

700 Participants
are divided into 4 treatment groups

Locations

8
Memorial Sloan Kettering Basking Ridge (Consent Only)07920, Basking RidgeNew Jersey, United States
Memorial Sloan Kettering Monmouth (Consent Only)07748, MiddletownNew Jersey, United States
Memorial Sloan Kettering Bergen (Consent Only)07645, MontvaleNew Jersey, United States
Memorial Sloan Kettering Suffolk- Commack (Consent Only)11725, CommackNew York, United States

Sponsors and collaborators

Memorial Sloan Kettering Cancer Center

Lead sponsor

Source ClinicalTrials.gov